Back to search
Allogeneic Hematopoietic Cell Transplantation (HCT)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Allogeneic Hematopoietic Cell Transplantation (HCT) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Allogeneic Hematopoietic Cell Transplantation (HCT) trials you may qualify forBackground: People living with HIV(PLWH) are at a higher risk for cancers that may be curable with a bone marrow transplant. HIV infection itself is no longer…
This phase I/II trial studies the side effects and best dose of pralatrexate in combination with bendamustine and total-body irradiation (TBI) followed by a don…
This is a Phase 2 study of the study drug, ivosidenib (a mutant IDH1 inhibitor), compared to placebo, given to patients with IDH1-mutant acute myeloid leukemia…
This randomized, open-label, parallel group, two-arm, multi-center assessment will compare IV BCV with IV CDV in adult and pediatric allogeneic HCT recipients w…
This is a multi-center, randomized, double-blinded, placebo controlled trial.
This trial studies the side effects and how well allogeneic cytomegalovirus-specific cytotoxic T lymphocytes (donor cytomegalovirus \[CMV\] specific cytotoxic T…
The purpose of this study is to see if conditioning regimens that include personalized rabbit ATG (P-rATG) help the immune system recover sooner and decrease th…
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.